Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic AF: Results of the FORWARD Trial

Summary

According to the results from the Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [FORWARD; NCT00597220], pharmacological supplementation with n-3 polyunsaturated fatty acids (PUFA) does not reduce recurrent atrial fibrillation.

  • Arrhythmias
  • Cardiology Clinical Trials
View Full Text
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic AF: Results of the FORWARD Trial
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Arrhythmias
Cardiology Clinical Trials